000130081 001__ 130081
000130081 005__ 20240319081001.0
000130081 0247_ $$2doi$$a10.3390/jcm11051258
000130081 0248_ $$2sideral$$a128158
000130081 037__ $$aART-2022-128158
000130081 041__ $$aeng
000130081 100__ $$0(orcid)0000-0002-5797-3909$$aLatorre, E.$$uUniversidad de Zaragoza
000130081 245__ $$aSpecial Issue “Clinical Advances in Chronic Intestinal Diseases Treatment”
000130081 260__ $$c2022
000130081 5060_ $$aAccess copy available to the general public$$fUnrestricted
000130081 5203_ $$aDuring the last decades, the management of patients with chronic intestinal diseases has experienced remarkable progress from both diagnostic and therapeutic point of view. Irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) are the best known and with the highest incidence and prevalence around the world among chronic intestinal pathologies. Both chronic conditions display a significant overlap in terms of symptoms, pathophysiology, and treatments. However, these chronic intestinal diseases are poorly characterized and the understanding about is limited. New clinical approaches with novel mechanisms of action may offer more efficient options for treatment of chronic intestinal diseases, especially in those patients who are not optimally characterized or controlled.
000130081 540__ $$9info:eu-repo/semantics/openAccess$$aby$$uhttp://creativecommons.org/licenses/by/3.0/es/
000130081 590__ $$a3.9$$b2022
000130081 591__ $$aMEDICINE, GENERAL & INTERNAL$$b58 / 169 = 0.343$$c2022$$dQ2$$eT2
000130081 592__ $$a0.935$$b2022
000130081 593__ $$aMedicine (miscellaneous)$$c2022$$dQ1
000130081 594__ $$a5.4$$b2022
000130081 655_4 $$ainfo:eu-repo/semantics/other$$vinfo:eu-repo/semantics/publishedVersion
000130081 700__ $$0(orcid)0000-0003-4758-3998$$aMesonero, J. E.$$uUniversidad de Zaragoza
000130081 7102_ $$11012$$2410$$aUniversidad de Zaragoza$$bDpto. Farmac.Fisiol.y Med.L.F.$$cÁrea Fisiología
000130081 7102_ $$11002$$2050$$aUniversidad de Zaragoza$$bDpto. Bioq.Biolog.Mol. Celular$$cÁrea Biología Celular
000130081 773__ $$g11, 5 (2022), 1258 [3 pp]$$pJ. clin.med.$$tJournal of Clinical Medicine$$x2077-0383
000130081 8564_ $$s186687$$uhttps://zaguan.unizar.es/record/130081/files/texto_completo.pdf$$yVersión publicada
000130081 8564_ $$s2863680$$uhttps://zaguan.unizar.es/record/130081/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000130081 909CO $$ooai:zaguan.unizar.es:130081$$particulos$$pdriver
000130081 951__ $$a2024-03-18-14:08:07
000130081 980__ $$aARTICLE